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Background: The purpose of the present controlled clinical trial was to assess the effect of a single 60 min
application of transcutaneous electrical nervous stimulation (TENS) at sensory stimulation threshold (STS), compared
to the application of motor stimulation threshold (MTS) as well as to untreatment, on the surface
electromyographic (sEMG) and kinesiographic activity of patients with tempormanbibular disorder (TMD).
Methods: Sixty female subjects, selected according to the inclusion/exclusion criteria, suffering from unilateral TMD
in remission were assigned to MTS, STS or untreatment. Pre- and post-treatment differences in the sEMG activity of
temporalis anterior (TA), masseter (MM), digastric (DA) and sternocleidomastoid muscles (SCM), as well in the
interocclusal distance (ID), within group were tested using the Wilcoxon test, while differences among groups were
assessed by Kruskal-Wallis test; the level of significance was set at p ≤ 0.05.
Results: Significant pre- and post-treatment differences were observed in MTS and STS groups, for TA and MM of
both sides; no significant difference was detected between MTS and STS groups. Kinesiographic results showed
that the vertical component of ID was significantly increased after TENS in MTS and STS groups.
Conclusions: STS TENS could be effective, as well as MTS, in reduce the sEMG activity of masticatory muscles and
to improve the ID of TMD patients in remission. Future studies are needed to confirm the results of the present
study. Clinical relevance. The present study demonstrates that the application of TENS is effective in reduce the
sEMG activity, as well as in increasing the ID of patients with TMD; our study did not support superior effectiveness
of MTS or STS.
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Temporomandibular disorder (TMD) is a collective term
that embraces a number of clinical problems that involve
the masticatory muscles, the temporomandibular joint
and the associated structures. [1] The diagnosis of TMD
is mainly based on clinical examination, even if add-
itional auxiliary tools are available for a supplemental
clinical investigation. Among those, surface electro-
myography (sEMG) has been proposed as supplemental
tool in TMD diagnosis: despite the fact that the reliabil-
ity of sEMG recordings from masticatory muscles is still
lacking general consensus [2,3], since several issues,
which are related to selectivity, reliability, and interpret-
ation of sEMG signals, remain to be resolved [4,5], it has
been suggested that sEMG could provide an objective
recording of muscular activity [6-8], at rest and during
functional activity, in a non-invasive way.
Transcutaneous electrical nervous stimulation (TENS)
has been suggested as a treatment strategy in the ther-
apy of TMD [9-11], since it has been showed to produce
an antalgic effect in symptomatic patients and a positive
relaxing effect on the masticatory muscles [12]. In clin-
ical practice and research investigation, TENS has been
administered at a variety of intensities as well of thresh-
old of stimulation, both for antalgic [13,14] and relaxing
purposes [15-17]. However, the effectiveness of TENS in
reducing the sEMG activity of masticatory muscles, in
patients with TMD, is still a debated question: differ-
ences, in terms of settings and types of TENS applica-
tions, among studies have been suggested to play an
important role in explaining the contrasting findings,
that have been observed in the literature [18-20]: inter-
estingly, two controlled studies [15,17], that recruited
patients with symptomatic and asymptomatic TMD,
respectively, using the same treatment design, that
consisted of a 60 min application of low intensity TENS
with a motor threshold of stimulation (MTS), reported a
significant reduction of sEMG activity of masticatory
muscles; in contrast, another controlled study, that
recruited patients with symptomatic TMD [16], using a
45 min application of high intensity TENS with a sen-
sorial threshold of stimulation (STS), observed a signifi-
cant reduction of pain intensity, and reported no
significant differences with regard to the muscular activ-
ity in the group receiving TENS application.
Interestingly, Moran and coworkers [21] showed that
TENS-mediated pain relief has a dose–response rela-
tionship, suggesting that intensity as well as threshold
stimulation could influence the effectiveness of TENS
application. These observations, could have important
implications in clinical practice and research, since no
optimal dosage as well as threshold of stimulation have
been defined in the treatment of patients with TMD.
Accordingly, no study is available to compare the effectof different threshold of stimulation on muscular activity
of patients with TMD.
Previously [17], we showed that MTS is effective in
reducing the sEMG activity of masticatory muscles; in
the present study we assess, the effect of motor threshold
of stimulation (MTS) TENS, compared to sensory thresh-
old application (STS) TENS on the muscular activity of
masticatory and neck muscles, of patients with TMD.
Methods
Subjects
This study was conducted in accordance with the Declar-
ation of Helsinki. The Committee on Ethics in Science of
the University of L’Aquila, L’Aquila, Italy approved the study
and informed consent was obtained from each subject.
Sixty female subjects suffering from unilateral TMD in
remission at least from 3 months, aged 24 to 30 years-
old (median age = 26 years), were recruited and divided
into three groups: twenty patients were assigned to a
single session of 60 m of MTS TENS; twenty patients
undergone a single session of 60 m of STS TENS; twenty
patients received a delayed TENS treatment after the
end of the study, and, therefore, this group received no
treatment during the entire duration of the study and
acted as control.
Selection criteria
Considering that jaw elevator muscle activity can be
influenced by oro-facial pain [22], gender [23], age [24],
occlusion [25], and hemispheric-dominance [26], only
patients that fulfilled the following inclusion criteria were
included in the study: age less than 30 years; female gen-
der; right-handed (7–10 points in Edinburgh inventory)
[27]; presence of complete permanent dentition, with the
exception of the third molars; normal occlusion; and diag-
nosis of unilateral arthrogenous TMD on the Research
Diagnostic Criteria for TMD (RDC/TMD) [28,29], Axis I,
groups II and III. Patients were excluded from the study if
they met one or more of the following exclusion criteria:
having pacemaker or other electrical devices, previous
experience of TENS or biofeedback, systemic diseases, his-
tory of local or general trauma, neurological or psychiatric
disorders, muscular diseases, cervical pain, bruxism, diag-
nosed by the presence of parafunctional facets and/or
anamnesis of parafunctional tooth clenching and/or grind-
ing; pregnancy, assumption of anti-inflammatory, anal-
gesic, antidepressant or myorelaxant drugs, fixed or
removable prostheses, fixed restorations that affected the
occlusal surfaces, or previous or concurrent orthodontic
or orthognathic treatment.
sEMG, TENS and kinesiographic measurements
All examinations were performed by one examiner (A.
M.), using an 8-channel surface electromyograph with
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channels, and filters of 50 Hz electromyography (K7/
EMG, Myotronics-Noromed, Inc., Tukwila WA, USA),
with disposable electrodes (Duotrode, bipolar surface
electrodes Ag-AgCl, 20 mm center to center distance,
Myotronics-Noromed, Inc., Tukwila WA, USA), for
sEMG recording. The right masseter (RMM), left mas-
seter (LMM), right anterior temporal (RTA), left anterior
temporal (LTA), right digastric (RDA), left digastric
(LDA), right sternocleidomastoid (RSCM), and left
sternocleidomastoid (LSCM) muscles were recorded.
The sEMG recordings and muscle activity was expressed
as the root mean square (RMS) of the amplitude,
expressed in μV [30]. Kinesiographic recordings were
performed using a kinesiograph (K7/CMS; Myotronics-
Noromed, Inc., Tukwila, WA, USA) that measures jaw
movements with an accuracy of 0.1 mm. An array of
lightweight (113 gr) with multiple sensors and
containing 8 magnetic sensors, tracked the motion of a
magnet (CMS Magnet; Myotronics-Noromed, Inc.,
Tukwila WA, USA), that was attached at the lower
inter-incisor point. The kinesiograph was interfaced with
a computer for data storage and subsequent software
analysis (K7 Program, Myotronics-Noromed, Inc.,
Tukwila WA, USA).
Positioning of sEMG, TENS electrodes and kinesiographic
array
The electrodes determine, to a large extent, the quality
of the recordings [31]. Electrodes were positioned on
LMM, RMM, LTA and RTA, as described by
Castroflorio et al. [6], as well on RDA, LDA [32], LSC
and RSC [33,34], A template was used to enabled the
exact reposition of the electrodes, in the occurrence of
malfuctioning. The ground electrode, which was larger
than the others and ensured a very good contact with
the skin, was positioned on the subject’s forehead to
ensure a common reference to the differential input of
the amplifier. The kinesiographic array was mounted
on the subject's head, and the optimal position of the
magnet for the recording of kinematic movements was
monitored by software.
Due to the noise inherent with the sEMG record-
ing, a special attention was paid to obtain reprodu-
cible and standardized recordings; approximately 15%
of the electrodes required a relocation after new
degreased, dry, jelly, and electrode fixation; however,
to obtain a reliable sEMG recording, the reliability
of signal captation of each electrodes was tested by
a noise test software (K7 Program, Myotronics-
Noromed, Inc., Tukwila WA, USA): only when the
software gave the absence of noise (corresponding to
the value provided by the software of 0.0), the sEMG
recording was started.Stimulation procedure
For TENS application a J5 Myomonitor TENS Unit
device (Myotronics-Noromed, Inc., Tukwila, WA, USA),
with disposable electrodes (Myotrode SG Electrodes,
Myotronics-Noromed, Inc., Tukwila, WA, USA) was
used: this low-frequency neurostimulator generates a
repetitive synchronous and bilateral stimulus, delivered
at 1.5 s intervals, with a variable amplitude of approxi-
mately 0–24 mA, a duration of 500 μs and a frequency
of 0.66 Hz. The two electrodes for TENS were placed
bilaterally over the cutaneous projection of the notch of
the V pair of cranial nerves, that is located between the
coronoid and condylar process and was retrieved by
manual palpation of the zone anterior to the tragus; a
third grounding electrode was placed in the center of
the back of the neck [15]; however, since in the area of
application of TENS, fibers of VII pair of cranial nerves
are present, MTS TENS resulted in the motor stimula-
tion of jaw elevator and facial muscles.
The stimulation procedure was performed under
kinesiographic recording, in order to assess the achieve-
ment and the absence of motor stimulation in the MTS
and STS group, respectively. In both MTS and STS
groups the amplitude of TENS stimulation was reached
starting from 0, with the stimulator turned on and the
rheostat, which controls amplitude, positioned on 0;
thus, the amplitude of stimulation was progressively
increased of 0.6 mA/s: in the MTS group the stimulation
was progressively increased until the contraction of the
elevator muscles of the jaw was observed on the
kinesiographic track.
In the STS group, the stimulation was progressively
increased until the patients reported the sensation of
pricking: a particular attention was paid to avoid the
reaching of the threshold of motor stimulation: indeed,
in this group, if any movement of the investigated mus-
cles was observed during the kinesiographic recording,
the patients was excluded from the study.
Recording procedure
Electromyographic and kinesiographic recordings were
conducted with patients comfortably seated on a
wooden chair with a straight back; patients were asked
to assume a relaxed position of the head. The measure-
ments were performed in a silent and comfortable envir-
onment. For sEMG recording, three consecutive tracks,
with a duration of 15 s, and withouth any interposing
phasic event, such as swallowing, voluntary movement
or clenching, were acquired with the mandible of the
patient in rest position. During the recordings, each sub-
ject was asked to keep his/her eyes closed, maintaining a
slight contact between his/her lips. The participants
received these instructions before the recordings. For
each patient, sEMG and kinesiographic measurements
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tion of TENS. Patients in the control group received no
treatment, and underwent sEMG and kinesiographic re-
cording at baseline and immediately after TENS.
For kinesiographic recording, the patients were asked
to close their eyes and, starting from the mandible rest
position, to occlude teeth; after 2 s from occlusal con-
tact, the patients were asked to quickly open and return
in occlusal contact (tap-tap phase); for each patient, at
least 3 consecutive tap-tap phases were recorded; the
achievement of occlusal contact during each tap-tap
phase was defined as the presence on the vertical com-
ponent (Figure 1, Blu line) of the kinesiographic tracing
of an horizontal line located at the same height of the
first occlusal contact (Figure 1). After the tap-tap phase,
the patients keep their habitual occlusal position for at
least 1 s, then, they were asked to protrude the man-
dible. Kinesiographic recording was started at the end of
the TENS session.
For kinesiographic measurements, the interocclusal
distance (ID) was recorded in its threedimensional com-
ponent: verticality (defined as the difference between
basal and the highest level of the blue line) (Figure 1),
anterior-posteriority (defined as the difference between
basal and highest level of the red line) (Figure 1), and
verticality/anterior-posteriority (V/AP) ratio.
Study design
TENS electrodes were placed in all patients, but the stimu-
lation was performed only in the MTS AND STS groups.Figure 1 Kinesiographic track. Ver (Verticality/Blu line) refer to vertical co
line) refer to anterio-posterior component of interocclusal distance. Lat (Lat
Line at the beginnig of the track refer to basal position of the mandible atThe stimulation procedure was performed by the same
operator who placed the electrodes (Figures 2 and 3).Sample size calculation
The sample size calculation determined that 16 subjects
per treatment arm would provide a 80% power to detect
a true difference of 0.6 μV among the three study groups
using the reduction in the mean RMS between LTA and
RTA as the primary outcome variable, assuming that the
common standard deviation is 0.6 μV. Accordingly, a
sample of 20 subjects per arm was recruited to over-
come the possibility of dropouts.Statistical analysis
Statistical analysis was performed using STATA 10
(StataCorp LP, College Station, TX, USA). The level of
significance was assumed to be p ≤ 0.05 for all tests.The
Shapiro-Wilk test indicated a non normal distribution of
the sEMG and kinesiographic data, as well of the
patient’s age in the three groups; therefore, pre- and
post-treatment within group differences in the sEMG
and kinesiographic data were analyzed using the Wilcoxon
test. Differences in the sEMG, kinesiographic data and age
among the three groups, were assessed by Kruskal-Wallis
test. Kinesiographic and sEMG data are expressed as
means and standard deviations (SD). Intraclass coefficient
correlation (ICC) was calculated to estimate the intra- and
inter-sessional reproducibility, according to the protocol
suggested by Castroflorio and coworkers [35].mponent of the interocclusal distance; AP (Anterior-Posteriority/Red
erality/Green line) refer to lateral component of interocclusal distance.
rest position.
Figure 2 sEMG and TENS electrodes positioning.
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All sixty female patients completed the study and no
droput occurred. The mean age was 25.5±1.3 in MST
group, 26.3 ± 1.2 in STS group and 25.4 ± 1.1 in the
control group; no significant differences were observed
in age among the three groups (p > 0.01).Figure 3 K7 electromyographic and kinesiographic instruments.Reproducibility
At the first sEMG recording, the mean ICC for investi-
gated muscles was 0.832, while in the second recording
the mean ICC was 0.803; globally, the ICC was 0.814.
SEMG and kinesiographic findings
At baseline, no significant difference in sEMG and
kinesiographic measurements was observed among the
three groups. In the MTS group, motor stimulation was
reached in 15–20 s, while in the STS the group sensory
stimulation was reached in 5–10 s.
Immediately after TENS, a reduction in RMS was
observed for all investigated muscles in MTS and STS
groups; in the control group, only RMM, LDA and RDA
showed a reduction in RMS values, even if these changes
were not statistically significant. Significant pre – post-
treatment differences were observed in the MTS and
STS groups, for LTA RTA LMM and RMM. Kruskal-
Wallis test revealed that RMS values of LTA RTA LMM
and RMM in the MTS and STS groups were signifi-
cantly reduced, in comparison with control group; how-
ever, no significant differences were observed between
MTS and STS groups at baseline or at post-treatment
timepoint (Table 1).
Kinesiographic results showed that the vertical compo-
nent of ID, as well as V/AP ratio were significantly
increased after TENS, in both MTS and STS groups; sig-
nificant differences were found for MTS and STS groups
in comparison with control group (Table 2); no signifi-
cant differences for any kinesiographic parameter was
observed between MTS and STS groups.
Discussion
In the present study, the effect of two different types of
TENS stimulation on the sEMG activity as well on the
kinesiographic pattern of patients with TMD in remis-
sion was investigated; the results suggest that both MTS
Table 1 Values of sEMG activity in the MTS, STS and control group
MTS group STS group CONTROL group
Baseline After TENS Baseline After TENS Baseline After TENS
LTA 2.79 (1.69) 1.62 (1.08) a,b 2.91 (1.48) 1.70 (0.99) a,b 2.69 (1.25) 3.18 (1.93)
RTA 2.87 (1.76) 1.71 (1.13) a,b 2.83 (1.46) 1.64 (1.07) a,b 2.93 (1.57) 3.36 (1.67)
LMM 1.59 (0.91) 1.17 (0.64) a,b 1.59 (1.17) 1.12 (0.78) a,b 1.37 (1.19) 1.39 (1.26)
RMM 1.47 (1.01) 1.11 (0.77) a,b 1.50 (1.19) 1.14 (0.54) a,b 1.51 (1.19) 1.42 (1.33)
LSM 2.44 (1.81) 2.23 (2.40) 2.51 (1.71) 2.52 (2.05) 2.19 (1.30) 2.38 (1.97)
RSM 2.28 (1.74) 2.24 (2.74) 2.39 (2.33) 2.27 (2.26) 2.46 (1.92) 2.65 (1.81)
LDA 1.99 (1.17) 1.79 (1.11) 1.91 (1.12) 1.82 (0.75) 1.79 (0.76) 1.64 (0.68)
RDA 2.16 (1.26) 1.95 (1.25) 1.98 (1.21) 1.76 (089) 1.94 (1.35) 1.89 (1.09)
Legend: MTS, motor threshold of stimulation; STS, sensorial threshold of stimulation; LTA, left temporalis anterior; RTA, right temporalis anterior; LMM, left
masseter muscle; RMM, right masseter muscle; LSM, left sternocleidomastoi muscle; RSM, right sternocleidomastoi muscle; LDA, left digastric anterior; RDA, right
digastric anterior.
Letters refer to significant change pre-post treatment (a) or among groups (b).
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LMM, RMM, LTA and LTA, as well in increasing the
inter-occlusal distance; furthermore, no significant dif-
ference was found between MTS and STS. These find-
ings are in agreement with those achieved by other
studies [15,16,35,36]; in particular Cooper and Kleinberg
[15] found that MTS application reduced the sEMG
activity of masticatory muscles, as well as symptoms;
however, even if the effect of MTS on sEMG values were
evaluated before and immediately after the MTS applica-
tion, changes in symptoms were evaluated after one and
three months, during which patients underwent an
additional treatment with orthosis; therefore, it is diffi-
cult to define the amount of reduction in sEMG activity
as well in symptoms, that could be attributed to MTS
application. Rodrigues et al. [16] evaluated the effects of
TENS on sEMG activity and pain of 19 patients suffer-
ing from TMD: a significant reduction on pain level, as
well on the sEMG activity of LTA and RTA, at rest, was
observed; however, this study used a high intensity STS
with a time of application of 45 min.; therefore, the dis-
crepancies in the settings of TENS make impossible
comparisons with our findings.
Some concerns have been claimed on the validity of
the sEMG recording in the diagnosis and monitoring of
TMD [2,3,37]; these concercens are mainly related to
the reliability of the sEMG recording and to its reprodu-
cibility: in the present study, the reproducibility of theTable 2 Kinesiographic values in the MT TENS, ST TENS and c
MTS TENS
Baseline After TENS Ba
Verticality 1.23 (0.72) 3.03 (1.17)a,b 1.2
Anterior-posteriority 0.61 (0.36) 0.78 (0.51) 0.5
V/AP Ratio 2.36 (1.18) 4.42 (3.06) a,b 2.1
Legend: MTS, motor threshold of stimulation; STS, sensorial threshold of stimulatio
Letters refer to significant change pre-post treatment (a) or between test (MST or SsEMG measurements was assessed through the protocol
suggested by Castroflorio et al. [38]; accordingly, a mean
ICC of 0.814 was obtained; this value is in agreement to
that reported by Castroflorio et al.[38] and could be con-
sidered as indicative of an excellent reproducibility [39].
With regard to the condition of the sEMG recording,
no general consensus has been reached in the literature
on what condition should be the most appropriate and
reliable for the reproducibility of the sEMG recording:
even if clenching has been suggested to be a more reli-
able and standardized condition for sEMG recording,
than rest position [7], it has been observed that in situa-
tions of chronic muscular pain, muscular contraction
ability is reduced due to the decrease in activity of the
agonist muscles and the increase in activity of the antag-
onist muscles [40-42]; in the present study we selected
only asymptomatic patients, that were in remission from
chronic pain accordingly and did not use clenching as
the condition for sEMG recording, but rest position of
the mandible, that has been suggested to be more reli-
able in asymptomatic patients [43].
To enhance the internal validity of the study and to
obtain an homogeneous sample, we used strict and
rigorous inclusion/exclusion criteria in the selection of
patients, and performed a sample size calculation, which
indicated that a minimum of 16 patients per group
would be required; it has been reported that TMDs
occur more frequently in women than man [44]: thisontrol group
STS TENS CONTROL
seline After TENS Baseline After TENS
5 (0.74) 2.94 (1.14) a,b 1.25 (0.79) 1.27 (1.09)
8 (0.47) 0.70 (0.38) 0.59(0.44) 0.64 (0.39)
5 (1.23) 4.20 (2.97) a,b 2.24 (1.18) 2.09 (1.46)
n; V/AP, verticality - anterior-posteriority ratio.
ST) and control group (b).
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ethnicity, gender, hemispheric-dominance, missing teeth,
occlusal alteration, the presence of systemic condition
that could affect the activity of muscles, nervous system
and joints, has been excluded to homogenize all groups
under study. These strict inclusion criteria were required
considering that the present was a pilot study.
The present study has an important limitation, since it
was not a randomized double-blind clinical trial: the
randomization process is performed to assign partici-
pants to study groups, such that the groups are balanced
for known and unknown risk factor, to minimize bias;
the absence of randomization may have introduced a
bias into the study.
Based on the findings of the present study, the applica-
tion of a single session of 60 min of STS is as effective
as MTS, in reducing the sEMG activity of LTA, RTA,
LMM and RMM at rest and in increasing the ID in
patients with TMD in remission. However, further stud-
ies are required to assess the effect of STS, compared to
MTS, on the sEMG and kinesiographic pattern of
patients with symptomatic TMD.
Conclusions
STS TENS could be effective, as well as MTS, in reduce
the sEMG activity of masticatory muscles and to
improve the ID of TMD patients in remission. Future
studies are needed to confirm the results of the present
study. Clinical relevance. The present study demon-
strates that the application of TENS is effective in
reduce the sEMG activity, as well as in increasing the ID
of patients with TMD; our study did not support super-
ior effectiveness of MTS or STS.
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